These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 12657367)

  • 1. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
    Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system and the eye in diabetes.
    Strain WD; Chaturvedi N
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):243-6. PubMed ID: 12584667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Para-inflammation in the aging retina.
    Xu H; Chen M; Forrester JV
    Prog Retin Eye Res; 2009 Sep; 28(5):348-68. PubMed ID: 19560552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species.
    Frey T; Antonetti DA
    Antioxid Redox Signal; 2011 Sep; 15(5):1271-84. PubMed ID: 21294655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway.
    Leal EC; Aveleira CA; Castilho AF; Serra AM; Baptista FI; Hosoya K; Forrester JV; Ambrósio AF
    Exp Eye Res; 2009 May; 88(5):983-91. PubMed ID: 19146853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tight junctions and loss of barrier function in pathophysiology.
    Harhaj NS; Antonetti DA
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1206-37. PubMed ID: 15109567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating diabetic retinopathy by tackling growth factor pathways.
    Chiarelli F; Giannini C; Di Marzio D; Mohn A
    Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of diabetic retinopathy].
    Pelikánová T
    Vnitr Lek; 2007 May; 53(5):498-505. PubMed ID: 17642432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
    Felinski EA; Antonetti DA
    Curr Eye Res; 2005 Nov; 30(11):949-57. PubMed ID: 16282129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in pathogenesis and treatment of diabetic retinopathy.
    Spranger J; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S438-50. PubMed ID: 11460590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for diabetic complications: Angiogenesis factor].
    Katsura Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():73-8. PubMed ID: 12430210
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroblastoma, apoptosis, and growth factors.
    Beierle EA; Dai W; Langham MR; Chen MK
    Am Surg; 2003 Jan; 69(1):28-31. PubMed ID: 12575776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.